Impact of hepatitis B and C co-infection on health-related quality of life in HIV positive individuals

Purpose Concurrent infection with HIV, hepatitis B virus (HBV), and hepatitis C virus (HCV) often occurs due to the commonality in risk factors for acquisition. Few studies have examined the effect of co-infection on health-related quality of life (HRQOL) in HIV positive individuals. Methods Ontario...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Quality of life research 2013-09, Vol.22 (7), p.1525-1535
Hauptverfasser: Gillis, Jennifer, Cooper, Curtis, Rourke, Sean, Rueda, Sergio, O'Brien, Kelly, Collins, Evan, Rachlis, Anita, Hart, Trevor A., Raboud, Janet
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1535
container_issue 7
container_start_page 1525
container_title Quality of life research
container_volume 22
creator Gillis, Jennifer
Cooper, Curtis
Rourke, Sean
Rueda, Sergio
O'Brien, Kelly
Collins, Evan
Rachlis, Anita
Hart, Trevor A.
Raboud, Janet
description Purpose Concurrent infection with HIV, hepatitis B virus (HBV), and hepatitis C virus (HCV) often occurs due to the commonality in risk factors for acquisition. Few studies have examined the effect of co-infection on health-related quality of life (HRQOL) in HIV positive individuals. Methods Ontario HIV Treatment Network Cohort Study (OCS) participants who completed an annual interviewer-administered questionnaire on up to three occasions were included. Generalized estimating equations (GEE) were used to assess the impact of HBV and HCV co-infection on physical and mental HRQOL component summary scores (range 0–100) as measured by the Medical Outcomes SF-36 health survey. Results As of March 2010, 1,223 participants had completed the questionnaire; 964 were HIV mono-infected, 128 were HIV–HBV co-infected, 112 were HIV–HCV co-infected, and 19 were HIV–HBV–HCV tri-infected. Eighty percent were male, median age 46 (IQR 40–53) years, 61 % Caucasian, median CD4 count 464 (IQR 319–636) cells/mm3, and 74 % had undetectable HIV viremia. Physical HRQOL was lower in HIV–HBV and HIV–HCV co-infected individuals (49.4 (IQR 42.0–53.9) and 48.1 (IQR 36.9–52.8) vs. 51.5 (IQR 45.0–55.4); p = 0.01 and
doi_str_mv 10.1007/s11136-012-0283-7
format Article
fullrecord <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_1552378255</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>24725187</jstor_id><sourcerecordid>24725187</sourcerecordid><originalsourceid>FETCH-LOGICAL-c460t-db1a879b945f8fbc62308f036927c2e19cc0716ecd2bcc37ed2a67caf1d82c0a3</originalsourceid><addsrcrecordid>eNqNkUtr3DAUhUVpaaZpf0AXLYJuulF7JdmStWyGpBkIZJN2K2Q9Oho8tmPJgfz7yjh90EUTEFyEvnPuEQehtxQ-UQD5OVFKuSBAGQHWcCKfoQ2tJSdMVOo52oASjChe8RP0KqUDADQK2Et0wjhIkJXaoLA7jsZmPAS896PJMceEz7DpHd5iO5DYB29zHHpczt6bLu_J5DuTvcO3s-livl-0XQwexx5f7r7jcUjF5W65u3gXXaHSa_QilOHfPMxT9O3i_GZ7Sa6uv-62X66IrQRk4lpqGqlaVdWhCa0VJWgTgAvFpGWeKmtBUuGtY621XHrHjJDWBOoaZsHwU_Rx9R2n4Xb2KetjTNZ3nen9MCdN65px2bC6fhytqoZRVeI8AS0xa05BFvTDP-hhmKe-_HmhOIiaAi8UXSk7DSlNPuhxikcz3WsKeqlWr9XqUq1eqtWL8_sH57k9evdb8avLArAVSOWp_-Gnv1b_x_XdKjqkPEx_TCvJatpI_hP7YLZG</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1433065103</pqid></control><display><type>article</type><title>Impact of hepatitis B and C co-infection on health-related quality of life in HIV positive individuals</title><source>MEDLINE</source><source>SpringerLink_现刊</source><source>JSTOR</source><creator>Gillis, Jennifer ; Cooper, Curtis ; Rourke, Sean ; Rueda, Sergio ; O'Brien, Kelly ; Collins, Evan ; Rachlis, Anita ; Hart, Trevor A. ; Raboud, Janet</creator><creatorcontrib>Gillis, Jennifer ; Cooper, Curtis ; Rourke, Sean ; Rueda, Sergio ; O'Brien, Kelly ; Collins, Evan ; Rachlis, Anita ; Hart, Trevor A. ; Raboud, Janet ; OHTN Cohort Study Group ; OHTN Cohort Study Group ; the OHTN Cohort Study Group</creatorcontrib><description>Purpose Concurrent infection with HIV, hepatitis B virus (HBV), and hepatitis C virus (HCV) often occurs due to the commonality in risk factors for acquisition. Few studies have examined the effect of co-infection on health-related quality of life (HRQOL) in HIV positive individuals. Methods Ontario HIV Treatment Network Cohort Study (OCS) participants who completed an annual interviewer-administered questionnaire on up to three occasions were included. Generalized estimating equations (GEE) were used to assess the impact of HBV and HCV co-infection on physical and mental HRQOL component summary scores (range 0–100) as measured by the Medical Outcomes SF-36 health survey. Results As of March 2010, 1,223 participants had completed the questionnaire; 964 were HIV mono-infected, 128 were HIV–HBV co-infected, 112 were HIV–HCV co-infected, and 19 were HIV–HBV–HCV tri-infected. Eighty percent were male, median age 46 (IQR 40–53) years, 61 % Caucasian, median CD4 count 464 (IQR 319–636) cells/mm3, and 74 % had undetectable HIV viremia. Physical HRQOL was lower in HIV–HBV and HIV–HCV co-infected individuals (49.4 (IQR 42.0–53.9) and 48.1 (IQR 36.9–52.8) vs. 51.5 (IQR 45.0–55.4); p = 0.01 and &lt;0.0001) compared to mono-infected individuals. In the multivariable GEE model, the negative impact of HCV remained significant (−2.18; p = 0.01) after adjusting for drug use, smoking, age, and gender. Unadjusted mental HRQOL was lower in HIV–HCV co-infected individuals (44.6 (IQR 34.6–54.0) vs. 48.9 (IQR 36.8–55.9); p = 0.03) compared to mono-infected individuals but no association of mental HRQOL with either co-infection was observed in multivariable GEE models. Conclusions HCV appears to negatively impact physical HRQOL suggesting a greater health burden for co-infected individuals. HBV and HCV co-infections were not related to lower mental HRQOL among people living with HIV/AIDS.</description><identifier>ISSN: 0962-9343</identifier><identifier>EISSN: 1573-2649</identifier><identifier>DOI: 10.1007/s11136-012-0283-7</identifier><identifier>PMID: 23070749</identifier><language>eng</language><publisher>Dordrecht: Springer</publisher><subject>Acquired immune deficiency syndrome ; Adult ; Alcohol drinking ; CD4 Lymphocyte Count ; Cohort analysis ; Cohort Studies ; Coinfection ; Comorbidity ; Coping ; Demography ; Drug use ; Female ; Health care networks ; Health Status ; Health surveys ; Hepatitis ; Hepatitis B ; Hepatitis B - complications ; Hepatitis B virus ; Hepatitis C ; Hepatitis C - complications ; HIV ; HIV Infections - complications ; HIV Infections - psychology ; HIV Infections - virology ; HIV-1 - isolation &amp; purification ; Hospitals ; Human immunodeficiency virus ; Humans ; Income estimates ; Infections ; Infectious diseases ; Laboratories ; Liver diseases ; Male ; Medicine ; Medicine &amp; Public Health ; Mental depression ; Mental health ; Middle Aged ; Ontario ; P values ; Public Health ; Quality of Life ; Quality of Life Research ; Questionnaires ; Sickness Impact Profile ; Sociodemographics ; Socioeconomic Factors ; Sociology ; Standard scores ; Stigma ; Surveys and Questionnaires ; Tranquilizing agents ; Viral Load ; Viremia - complications ; Viremia - immunology</subject><ispartof>Quality of life research, 2013-09, Vol.22 (7), p.1525-1535</ispartof><rights>Springer Science+Business Media Dordrecht 2012</rights><rights>Springer Science+Business Media Dordrecht 2013</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c460t-db1a879b945f8fbc62308f036927c2e19cc0716ecd2bcc37ed2a67caf1d82c0a3</citedby><cites>FETCH-LOGICAL-c460t-db1a879b945f8fbc62308f036927c2e19cc0716ecd2bcc37ed2a67caf1d82c0a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/24725187$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/24725187$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>315,781,785,804,27926,27927,41490,42559,51321,58019,58252</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23070749$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gillis, Jennifer</creatorcontrib><creatorcontrib>Cooper, Curtis</creatorcontrib><creatorcontrib>Rourke, Sean</creatorcontrib><creatorcontrib>Rueda, Sergio</creatorcontrib><creatorcontrib>O'Brien, Kelly</creatorcontrib><creatorcontrib>Collins, Evan</creatorcontrib><creatorcontrib>Rachlis, Anita</creatorcontrib><creatorcontrib>Hart, Trevor A.</creatorcontrib><creatorcontrib>Raboud, Janet</creatorcontrib><creatorcontrib>OHTN Cohort Study Group</creatorcontrib><creatorcontrib>OHTN Cohort Study Group</creatorcontrib><creatorcontrib>the OHTN Cohort Study Group</creatorcontrib><title>Impact of hepatitis B and C co-infection on health-related quality of life in HIV positive individuals</title><title>Quality of life research</title><addtitle>Qual Life Res</addtitle><addtitle>Qual Life Res</addtitle><description>Purpose Concurrent infection with HIV, hepatitis B virus (HBV), and hepatitis C virus (HCV) often occurs due to the commonality in risk factors for acquisition. Few studies have examined the effect of co-infection on health-related quality of life (HRQOL) in HIV positive individuals. Methods Ontario HIV Treatment Network Cohort Study (OCS) participants who completed an annual interviewer-administered questionnaire on up to three occasions were included. Generalized estimating equations (GEE) were used to assess the impact of HBV and HCV co-infection on physical and mental HRQOL component summary scores (range 0–100) as measured by the Medical Outcomes SF-36 health survey. Results As of March 2010, 1,223 participants had completed the questionnaire; 964 were HIV mono-infected, 128 were HIV–HBV co-infected, 112 were HIV–HCV co-infected, and 19 were HIV–HBV–HCV tri-infected. Eighty percent were male, median age 46 (IQR 40–53) years, 61 % Caucasian, median CD4 count 464 (IQR 319–636) cells/mm3, and 74 % had undetectable HIV viremia. Physical HRQOL was lower in HIV–HBV and HIV–HCV co-infected individuals (49.4 (IQR 42.0–53.9) and 48.1 (IQR 36.9–52.8) vs. 51.5 (IQR 45.0–55.4); p = 0.01 and &lt;0.0001) compared to mono-infected individuals. In the multivariable GEE model, the negative impact of HCV remained significant (−2.18; p = 0.01) after adjusting for drug use, smoking, age, and gender. Unadjusted mental HRQOL was lower in HIV–HCV co-infected individuals (44.6 (IQR 34.6–54.0) vs. 48.9 (IQR 36.8–55.9); p = 0.03) compared to mono-infected individuals but no association of mental HRQOL with either co-infection was observed in multivariable GEE models. Conclusions HCV appears to negatively impact physical HRQOL suggesting a greater health burden for co-infected individuals. HBV and HCV co-infections were not related to lower mental HRQOL among people living with HIV/AIDS.</description><subject>Acquired immune deficiency syndrome</subject><subject>Adult</subject><subject>Alcohol drinking</subject><subject>CD4 Lymphocyte Count</subject><subject>Cohort analysis</subject><subject>Cohort Studies</subject><subject>Coinfection</subject><subject>Comorbidity</subject><subject>Coping</subject><subject>Demography</subject><subject>Drug use</subject><subject>Female</subject><subject>Health care networks</subject><subject>Health Status</subject><subject>Health surveys</subject><subject>Hepatitis</subject><subject>Hepatitis B</subject><subject>Hepatitis B - complications</subject><subject>Hepatitis B virus</subject><subject>Hepatitis C</subject><subject>Hepatitis C - complications</subject><subject>HIV</subject><subject>HIV Infections - complications</subject><subject>HIV Infections - psychology</subject><subject>HIV Infections - virology</subject><subject>HIV-1 - isolation &amp; purification</subject><subject>Hospitals</subject><subject>Human immunodeficiency virus</subject><subject>Humans</subject><subject>Income estimates</subject><subject>Infections</subject><subject>Infectious diseases</subject><subject>Laboratories</subject><subject>Liver diseases</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Mental depression</subject><subject>Mental health</subject><subject>Middle Aged</subject><subject>Ontario</subject><subject>P values</subject><subject>Public Health</subject><subject>Quality of Life</subject><subject>Quality of Life Research</subject><subject>Questionnaires</subject><subject>Sickness Impact Profile</subject><subject>Sociodemographics</subject><subject>Socioeconomic Factors</subject><subject>Sociology</subject><subject>Standard scores</subject><subject>Stigma</subject><subject>Surveys and Questionnaires</subject><subject>Tranquilizing agents</subject><subject>Viral Load</subject><subject>Viremia - complications</subject><subject>Viremia - immunology</subject><issn>0962-9343</issn><issn>1573-2649</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqNkUtr3DAUhUVpaaZpf0AXLYJuulF7JdmStWyGpBkIZJN2K2Q9Oho8tmPJgfz7yjh90EUTEFyEvnPuEQehtxQ-UQD5OVFKuSBAGQHWcCKfoQ2tJSdMVOo52oASjChe8RP0KqUDADQK2Et0wjhIkJXaoLA7jsZmPAS896PJMceEz7DpHd5iO5DYB29zHHpczt6bLu_J5DuTvcO3s-livl-0XQwexx5f7r7jcUjF5W65u3gXXaHSa_QilOHfPMxT9O3i_GZ7Sa6uv-62X66IrQRk4lpqGqlaVdWhCa0VJWgTgAvFpGWeKmtBUuGtY621XHrHjJDWBOoaZsHwU_Rx9R2n4Xb2KetjTNZ3nen9MCdN65px2bC6fhytqoZRVeI8AS0xa05BFvTDP-hhmKe-_HmhOIiaAi8UXSk7DSlNPuhxikcz3WsKeqlWr9XqUq1eqtWL8_sH57k9evdb8avLArAVSOWp_-Gnv1b_x_XdKjqkPEx_TCvJatpI_hP7YLZG</recordid><startdate>20130901</startdate><enddate>20130901</enddate><creator>Gillis, Jennifer</creator><creator>Cooper, Curtis</creator><creator>Rourke, Sean</creator><creator>Rueda, Sergio</creator><creator>O'Brien, Kelly</creator><creator>Collins, Evan</creator><creator>Rachlis, Anita</creator><creator>Hart, Trevor A.</creator><creator>Raboud, Janet</creator><general>Springer</general><general>Springer Netherlands</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7WY</scope><scope>7WZ</scope><scope>7X7</scope><scope>7XB</scope><scope>87Z</scope><scope>88E</scope><scope>88G</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8FL</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BEZIV</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FRNLG</scope><scope>FYUFA</scope><scope>F~G</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>K60</scope><scope>K6~</scope><scope>K9.</scope><scope>KB0</scope><scope>L.-</scope><scope>M0C</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>NAPCQ</scope><scope>PQBIZ</scope><scope>PQBZA</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope><scope>7U9</scope><scope>H94</scope><scope>ASE</scope><scope>FPQ</scope><scope>K6X</scope></search><sort><creationdate>20130901</creationdate><title>Impact of hepatitis B and C co-infection on health-related quality of life in HIV positive individuals</title><author>Gillis, Jennifer ; Cooper, Curtis ; Rourke, Sean ; Rueda, Sergio ; O'Brien, Kelly ; Collins, Evan ; Rachlis, Anita ; Hart, Trevor A. ; Raboud, Janet</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c460t-db1a879b945f8fbc62308f036927c2e19cc0716ecd2bcc37ed2a67caf1d82c0a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Acquired immune deficiency syndrome</topic><topic>Adult</topic><topic>Alcohol drinking</topic><topic>CD4 Lymphocyte Count</topic><topic>Cohort analysis</topic><topic>Cohort Studies</topic><topic>Coinfection</topic><topic>Comorbidity</topic><topic>Coping</topic><topic>Demography</topic><topic>Drug use</topic><topic>Female</topic><topic>Health care networks</topic><topic>Health Status</topic><topic>Health surveys</topic><topic>Hepatitis</topic><topic>Hepatitis B</topic><topic>Hepatitis B - complications</topic><topic>Hepatitis B virus</topic><topic>Hepatitis C</topic><topic>Hepatitis C - complications</topic><topic>HIV</topic><topic>HIV Infections - complications</topic><topic>HIV Infections - psychology</topic><topic>HIV Infections - virology</topic><topic>HIV-1 - isolation &amp; purification</topic><topic>Hospitals</topic><topic>Human immunodeficiency virus</topic><topic>Humans</topic><topic>Income estimates</topic><topic>Infections</topic><topic>Infectious diseases</topic><topic>Laboratories</topic><topic>Liver diseases</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Mental depression</topic><topic>Mental health</topic><topic>Middle Aged</topic><topic>Ontario</topic><topic>P values</topic><topic>Public Health</topic><topic>Quality of Life</topic><topic>Quality of Life Research</topic><topic>Questionnaires</topic><topic>Sickness Impact Profile</topic><topic>Sociodemographics</topic><topic>Socioeconomic Factors</topic><topic>Sociology</topic><topic>Standard scores</topic><topic>Stigma</topic><topic>Surveys and Questionnaires</topic><topic>Tranquilizing agents</topic><topic>Viral Load</topic><topic>Viremia - complications</topic><topic>Viremia - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gillis, Jennifer</creatorcontrib><creatorcontrib>Cooper, Curtis</creatorcontrib><creatorcontrib>Rourke, Sean</creatorcontrib><creatorcontrib>Rueda, Sergio</creatorcontrib><creatorcontrib>O'Brien, Kelly</creatorcontrib><creatorcontrib>Collins, Evan</creatorcontrib><creatorcontrib>Rachlis, Anita</creatorcontrib><creatorcontrib>Hart, Trevor A.</creatorcontrib><creatorcontrib>Raboud, Janet</creatorcontrib><creatorcontrib>OHTN Cohort Study Group</creatorcontrib><creatorcontrib>OHTN Cohort Study Group</creatorcontrib><creatorcontrib>the OHTN Cohort Study Group</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database (ProQuest)</collection><collection>ABI/INFORM Complete</collection><collection>ABI/INFORM Global (PDF only)</collection><collection>ProQuest_Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ABI/INFORM Collection</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database (Proquest)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ABI/INFORM Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest Business Premium Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Business Premium Collection (Alumni)</collection><collection>Health Research Premium Collection</collection><collection>ABI/INFORM Global (Corporate)</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>ProQuest Business Collection (Alumni Edition)</collection><collection>ProQuest Business Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ABI/INFORM Professional Advanced</collection><collection>ABI/INFORM Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Psychology Database (ProQuest)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>One Business (ProQuest)</collection><collection>ProQuest One Business (Alumni)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>British Nursing Index</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>British Nursing Index</collection><jtitle>Quality of life research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gillis, Jennifer</au><au>Cooper, Curtis</au><au>Rourke, Sean</au><au>Rueda, Sergio</au><au>O'Brien, Kelly</au><au>Collins, Evan</au><au>Rachlis, Anita</au><au>Hart, Trevor A.</au><au>Raboud, Janet</au><aucorp>OHTN Cohort Study Group</aucorp><aucorp>OHTN Cohort Study Group</aucorp><aucorp>the OHTN Cohort Study Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Impact of hepatitis B and C co-infection on health-related quality of life in HIV positive individuals</atitle><jtitle>Quality of life research</jtitle><stitle>Qual Life Res</stitle><addtitle>Qual Life Res</addtitle><date>2013-09-01</date><risdate>2013</risdate><volume>22</volume><issue>7</issue><spage>1525</spage><epage>1535</epage><pages>1525-1535</pages><issn>0962-9343</issn><eissn>1573-2649</eissn><abstract>Purpose Concurrent infection with HIV, hepatitis B virus (HBV), and hepatitis C virus (HCV) often occurs due to the commonality in risk factors for acquisition. Few studies have examined the effect of co-infection on health-related quality of life (HRQOL) in HIV positive individuals. Methods Ontario HIV Treatment Network Cohort Study (OCS) participants who completed an annual interviewer-administered questionnaire on up to three occasions were included. Generalized estimating equations (GEE) were used to assess the impact of HBV and HCV co-infection on physical and mental HRQOL component summary scores (range 0–100) as measured by the Medical Outcomes SF-36 health survey. Results As of March 2010, 1,223 participants had completed the questionnaire; 964 were HIV mono-infected, 128 were HIV–HBV co-infected, 112 were HIV–HCV co-infected, and 19 were HIV–HBV–HCV tri-infected. Eighty percent were male, median age 46 (IQR 40–53) years, 61 % Caucasian, median CD4 count 464 (IQR 319–636) cells/mm3, and 74 % had undetectable HIV viremia. Physical HRQOL was lower in HIV–HBV and HIV–HCV co-infected individuals (49.4 (IQR 42.0–53.9) and 48.1 (IQR 36.9–52.8) vs. 51.5 (IQR 45.0–55.4); p = 0.01 and &lt;0.0001) compared to mono-infected individuals. In the multivariable GEE model, the negative impact of HCV remained significant (−2.18; p = 0.01) after adjusting for drug use, smoking, age, and gender. Unadjusted mental HRQOL was lower in HIV–HCV co-infected individuals (44.6 (IQR 34.6–54.0) vs. 48.9 (IQR 36.8–55.9); p = 0.03) compared to mono-infected individuals but no association of mental HRQOL with either co-infection was observed in multivariable GEE models. Conclusions HCV appears to negatively impact physical HRQOL suggesting a greater health burden for co-infected individuals. HBV and HCV co-infections were not related to lower mental HRQOL among people living with HIV/AIDS.</abstract><cop>Dordrecht</cop><pub>Springer</pub><pmid>23070749</pmid><doi>10.1007/s11136-012-0283-7</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0962-9343
ispartof Quality of life research, 2013-09, Vol.22 (7), p.1525-1535
issn 0962-9343
1573-2649
language eng
recordid cdi_proquest_miscellaneous_1552378255
source MEDLINE; SpringerLink_现刊; JSTOR
subjects Acquired immune deficiency syndrome
Adult
Alcohol drinking
CD4 Lymphocyte Count
Cohort analysis
Cohort Studies
Coinfection
Comorbidity
Coping
Demography
Drug use
Female
Health care networks
Health Status
Health surveys
Hepatitis
Hepatitis B
Hepatitis B - complications
Hepatitis B virus
Hepatitis C
Hepatitis C - complications
HIV
HIV Infections - complications
HIV Infections - psychology
HIV Infections - virology
HIV-1 - isolation & purification
Hospitals
Human immunodeficiency virus
Humans
Income estimates
Infections
Infectious diseases
Laboratories
Liver diseases
Male
Medicine
Medicine & Public Health
Mental depression
Mental health
Middle Aged
Ontario
P values
Public Health
Quality of Life
Quality of Life Research
Questionnaires
Sickness Impact Profile
Sociodemographics
Socioeconomic Factors
Sociology
Standard scores
Stigma
Surveys and Questionnaires
Tranquilizing agents
Viral Load
Viremia - complications
Viremia - immunology
title Impact of hepatitis B and C co-infection on health-related quality of life in HIV positive individuals
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T22%3A42%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Impact%20of%20hepatitis%20B%20and%20C%20co-infection%20on%20health-related%20quality%20of%20life%20in%20HIV%20positive%20individuals&rft.jtitle=Quality%20of%20life%20research&rft.au=Gillis,%20Jennifer&rft.aucorp=OHTN%20Cohort%20Study%20Group&rft.date=2013-09-01&rft.volume=22&rft.issue=7&rft.spage=1525&rft.epage=1535&rft.pages=1525-1535&rft.issn=0962-9343&rft.eissn=1573-2649&rft_id=info:doi/10.1007/s11136-012-0283-7&rft_dat=%3Cjstor_proqu%3E24725187%3C/jstor_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1433065103&rft_id=info:pmid/23070749&rft_jstor_id=24725187&rfr_iscdi=true